Senators Curtis and Rosen introduced a bill to help reduce the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs. Their bipartisan Expanding Access to Affordable Prescription Drugs and Medical Devices Act will create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status, to support this critical industry and bolster nonprofit manufacturer production so more Americans can have access to lower cost medicine.
I will support legislation to lower the cost of prescription drugs and medical devices, prevent drug shortages, boost domestic production, and create more jobs by establishing a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status.
Occurrences
"Utahns and their families look to Congress to help cut red tape and streamline innovation, and alongside Senator Rosen, this legislation will help secure the domestic supply chain and empower nonprofit manufacturers to improve our most vulnerable health care markets."
Evidence
The member page lists S.3325, "Expanding Access to Affordable Drugs and Medical Devices Act," with latest action "Senate - 12/03/2025 Read twice and referred to the Committee on Finance."
The press release says Senators Rosen and Curtis introduced a bipartisan bill that would "create a clear pathway for nonprofit drug and medical device manufacturers to receive tax-exempt status" and lower costs of prescription drugs and medical devices.
Assessments
Curtis made the promised federal legislative support action during his Senate term by introducing bipartisan legislation with Senator Rosen to create a clear tax-exempt pathway for nonprofit drug and medical device manufacturers, matching the mechanism described in the promise. The bill had only been introduced and referred, so the broader policy outcome was not enacted, but the promise was framed as supporting legislation rather than guaranteeing passage.